These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1789802)

  • 1. Plasma high density lipoprotein particle size alteration by simvastatin treatment in patients with hypercholesterolaemia.
    Johansson J; Mölgaard J; Olsson AG
    Atherosclerosis; 1991 Dec; 91(3):175-84. PubMed ID: 1789802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia.
    Zhao SP; Hollaar L; van 't Hooft FM; Smelt AH; Gevers Leuven JA; van der Laarse A
    Clin Chim Acta; 1991 Dec; 203(2-3):109-17. PubMed ID: 1777975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of simvastatin on high density lipoprotein subfractions and apolipoproteins in type IIa hypercholesterolemia.
    Crook D; Bruce R; Worthington M; Mulcahy D; Patterson D; Wynn V
    Cardiovasc Drugs Ther; 1992 Dec; 6(6):633-9. PubMed ID: 1292582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.
    Thiery J; Creutzfeldt C; Creutzfeldt W; Walli AK; Seidel D
    Klin Wochenschr; 1990 Aug; 68(16):814-22. PubMed ID: 2214604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications.
    Watts GF; Cummings MH; Umpleby M; Quiney JR; Naoumova R; Thompson GR; Sönksen PH
    Eur J Clin Invest; 1995 Aug; 25(8):559-67. PubMed ID: 7589011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.
    Bruckert E; De Gennes JL; Malbecq W; Baigts F
    Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of simvastatin treatment on the low-density lipoprotein subfraction profile and composition in familial hypercholesterolaemia.
    de Graaf J; Demacker PN; Stalenhoef AF
    Neth J Med; 1993 Dec; 43(5-6):254-61. PubMed ID: 8107933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin and bezafibrate: effects on serum lipoproteins and lecithin: cholesterol acyltransferase activity in familial hypercholesterolaemia.
    Weisweiler P
    Eur J Clin Pharmacol; 1988; 35(6):579-83. PubMed ID: 3234467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of simvastatin in patients with drug resistant familial hypercholesterolaemia.
    Lewis-Barned NJ; Ball MJ
    N Z Med J; 1992 Jul; 105(938):284-6. PubMed ID: 1495661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia.
    Steinmetz A; Schwartz T; Hehnke U; Kaffarnik H
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):563-70. PubMed ID: 8847874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Close correlation between high-density lipoprotein and triglycerides in normotriglyceridaemia.
    Johansson J; Walldius G; Carlson LA
    J Intern Med; 1992 Jul; 232(1):43-51. PubMed ID: 1640191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ketoconazole on plasma lipids and lipoprotein(a) in familial hypercholesterolaemia, compared with simvastatin.
    Stalenhoef AF; Stuyt PM; de Graaf J
    Neth J Med; 1997 Jul; 51(1):10-5. PubMed ID: 9260485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia.
    Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D
    Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with simvastatin compared with cholestyramine.
    Erkelens DW; Baggen MG; Van Doormaal JJ; Kettner M; Koningsberger JC; Mol MJ
    Drugs; 1988; 36 Suppl 3():87-92. PubMed ID: 3254824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercholesterolemia in non-insulin-dependent diabetes mellitus: different effect of simvastatin on VLDL and LDL cholesterol levels.
    Cassader M; Ruiu G; Gambino R; Alemanno N; Veglia F; Pagano G
    Atherosclerosis; 1993 Feb; 99(1):47-53. PubMed ID: 8461059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of simvastatin, bezafibrate and gemfibrozil on the quantity and composition of plasma lipoproteins.
    Nakandakare E; Garcia RC; Rocha JC; Sperotto G; Oliveira HC; Quintão EC
    Atherosclerosis; 1990 Dec; 85(2-3):211-7. PubMed ID: 2102085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin.
    Nestel P; Simons L; Barter P; Clifton P; Colquhoun D; Hamilton-Craig I; Sikaris K; Sullivan D
    Atherosclerosis; 1997 Mar; 129(2):231-9. PubMed ID: 9105566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia.
    Mol MJ; Erkelens DW; Gevers Leuven JA; Schouten JA; Stalenhoef AF
    Atherosclerosis; 1988 Feb; 69(2-3):131-7. PubMed ID: 3279966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin increases plasma NO2- and NO3- levels in patients with hypercholesterolemia.
    Nakashima Y; Toyokawa Y; Tanaka S; Yamashita K; Yashiro A; Tasaki H; Kuroiwa A
    Atherosclerosis; 1996 Nov; 127(1):43-7. PubMed ID: 9006803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.